The mTOR Pathway in Breast Cancer

ISSN： 1083-3021

Source： Journal of Mammary Gland Biology and Neoplasia, Vol.11, Iss.1, 2006-01, pp. : 53-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of mTOR pathway for cancer therapy, moving on from rapalogs to TORKinibs

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3390-3392

John Wiley & Sons Inc

Access to resources Recommend Favorite

mTOR

By Marin Philippe Meffre Julie Bockaert Joël

Médecine/sciences, Vol. 29, Iss. 1, 2013-01 ,pp. : 28-30

Edp Sciences

Access to resources Recommend Favorite

Inhibition of the mTOR pathway: A possible protective role in coronary artery disease

By Tarantino Giovanni Capone Domenico

Annals of Medicine, Vol. 45, Iss. 4, 2013-06 ,pp. : 348-356

Informa Healthcare

Access to resources Recommend Favorite

Alterations of the mTOR pathway in hepatic angiomyolipoma with emphasis on the epithelioid variant and loss of heterogeneity of TSC1/TSC2

HISTOPATHOLOGY, Vol. 66, Iss. 5, 2015-04 ,pp. : 695-705

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2−/− mice

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 4, 2015-04 ,pp. : 1451-1463

John Wiley & Sons Inc

Access to resources Recommend Favorite